Stockreport

ABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative Diseases

I-MAB - American Depositary Shares  (IMAB) 
PDF - ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases- Programs will leverage ABL Bio's Grabody-B platform tec [Read more]